View in EDS

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).

Saved in:
Bibliographic Details
Title: A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).
Authors: Argiris A; Hygeia Hospital, Athens, Greece; University of Texas Health Science Center at San Antonio, San Antonio, TX. Electronic address: athanassios.argiris@gmail.com., Miao J; SWOG Statistics and Data Management Center, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA., Cristea MC; City of Hope, Duarte, CA., Chen AM; University of Kansas, Kansas City, KS [previous]/University of California Irvine, Irvine, CA., Sands JM; Lahey Hospital & Medical Center, Burlington, MA [previous]/Dana-Farber Cancer Institute, Boston, MA., Decker RH; Yale University, New Haven, CT., Gettinger SN; Yale University, New Haven, CT., Daly ME; University of California Davis, Sacramento, CA., Faller BA; Heartland NCORP/Missouri Baptist Medical Center, Saint Louis, MO., Albain KS; Loyola University Chicago Stritch School of Medicine, Maywood, IL., Yanagihara RH; Hawaii MU-NCORP/Straub Clinic & Hospital, Honolulu, HI., Garland LL; University of Arizona, Tucson, AZ., Byers LA; MD Anderson Cancer Center, Houston, TX., Wang D; Henry Ford Hospital, Detroit, MI., Koczywas M; City of Hope, Duarte, CA., Redman MW; SWOG Statistics and Data Management Center, Seattle, WA; Fred Hutchinson Cancer Research Center, Seattle, WA., Kelly K; University of California Davis, Sacramento, CA., Gandara DR; University of California Davis, Sacramento, CA.
Source: Clinical lung cancer [Clin Lung Cancer] 2021 Jul; Vol. 22 (4), pp. 313-323.e1. Date of Electronic Publication: 2021 Feb 19.
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1938-0690
DOI:10.1016/j.cllc.2021.02.009